Bolt Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. 

CEO
William P. Quinn
CEOWilliam P. Quinn
Employees
52
Employees52
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2015
Founded2015
Employees
52
Employees52

BOLT Key Statistics

Market cap
10.79M
Market cap10.79M
Price-Earnings ratio
-0.17
Price-Earnings ratio-0.17
Dividend yield
Dividend yield
Average volume
18.84K
Average volume18.84K
High today
$5.88
High today$5.88
Low today
$5.52
Low today$5.52
Open price
$5.88
Open price$5.88
Volume
24.77K
Volume24.77K
52 Week high
$15.60
52 Week high$15.60
52 Week low
$5.20
52 Week low$5.20

People also own

Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.